CGD Policy Blogs
A four year study of a pneumococcal vaccine in the Gambia, published today's The Lancet (free registration), finds that the vaccine reduced childhood mortality by 16 percent in children who received the pneumococcal conjugate vaccine.
Dr. Lee Jong-wook, the Director-General of the World Health Organization (WHO) said:
CGD senior fellow, Steve Radelet and MCC CEO Paul Applegarth were featured guests on WAMU's Kojo Nnamdi show on Monday, March 21. The show provided a public platform for discussion about the MCC approach, the pace of its progress to date, and how the MCA fits into broader U.S. policy towards the developing world.
We have decided to launch the report of the Center for Global Development Working Group, "Making Markets for Vaccines", on World Health Day, April 7th 2005.
We've been lucky to get some great speakers for the event. The line-up so far includes:
The Harvard Business School Journal Working Knowledge recently published an interview with Michael Kremer and Rachel Glennerster discussing "pull mechanisms" to encourage commercial vaccine R&D efforts for developing countries.
A new study published today in Nature (abstract here) suggests that there may have been as many as half a billion cases of Plasmodium falciparum across the world in 2002.
More than two-thirds of these occurred in Africa, where this more deadly form of malaria mostly affects children under-five. But far more cases than previously thought take place in SE Asia.
Because there are so many informed voices (and differing opinions) on issues relating to advance market commitments to vaccine development, we hope periodically to include brief interviews on this site -- and encourage readers to post follow-up comments and questions. If you have recommendations on appropriate candidates for interview, post a comment or feel free to send me an email..
There is a good article about vaccines in today's FT, which quotes the work that we have been doing: